Djordje Atanackovic MD

Hematology•Baltimore, MD

Associate Professor, Internal Medicine, University of Utah Sch of Med

Request appointment

655 W. Baltimore StreetBaltimore, MD 21201
Book by Phone+1(443) 998-4698
Fax+1 410-328-6559

Overview of Dr. Atanackovic

Dr. Djordje Atanackovic is a hematologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and University of Utah Health. He received his medical degree from Freie University Berlin Faculty of Medicine and has been in practice 28 years. He is one of 22 doctors at University of Utah Health and one of 11 doctors at University of Maryland Medical Center who specialize in Hematology. He has more than 100 publications and over 500 citings.

Education & Training

Freie University Berlin Faculty of MedicineClass of 1998

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

UT State Medical License 2013 - 2028
MD State Medical License 2020 - 2026

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017

Publications & Presentations

PubMed

Beyond the typical immune effector cell-associated neurotoxicity syndrome: Characterizing non-immune effector cell-associated neurotoxicity syndrome neurological compl...
Melissa A Nicholas, Abdulaziz Abu-Haimed, Faisal Abushullaih, Emily N Davidson, Graeme A Fenton
Neuro-Oncology Advances. 2026-08-05
Predictors of Rehabilitation Utilization After CAR T-Cell Therapy.
Hanan Alharthy, Abdulaziz Abu-Haimed, Renu E Thomas, Graeme A Fenton, Justin W Kehm
Transplantation and Cellular Therapy. 2026-06-26
1 citations
Preventing trogocytosis by cathepsin B inhibition augments CAR T-cell function.
Kenneth A Dietze, Kiet Nguyen, Aashli Pathni, Frank Fazekas, Wenxiang Sun
Signal Transduction and Targeted Therapy. 2026-04-22

Abstracts/Posters

B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-Analysis
Djordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

CAR T-Cell Persistence After Treatment Can Lead to Bone Marrow Failure, Fatal Immune Collapse in Multiple MyelomaMay 21st, 2026
University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical TrialNovember 25th, 2024
New Cancer Treatment Changing Outlook for Those with Blood CancersJuly 11th, 2022